Taiwan News2d
China's First IGF-1R Monoclonal Antibody: Innovent Announces NMPA approval of SYCUME® for the Treatment of Thyroid Eye Disease
SAN FRANCISCO and SUZHOU, China, March 14, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
TMCnet9d
argenx Highlights FcRn Leadership with Long-term Data and Transformational Patient Outcomes at the American Academy of Neurology 2025 Annual Meeting
Infusion-Related Reactions. VYVGART HYTRULO can cause infusion-related reactions. The most frequent symptoms and signs reported with efgartigimod alfa-fcab were high blood pressure, chills, shivering, ...
BioWorld14d
Immunostimulatory fusion protein selectively activates NFAT pathway in cytotoxic T cells
Immunostimulant therapy using agonistic cytokines or activating antibodies has been associated with off-target side effects, failure to preferentially activate cytotoxic lymphocytes (CTLs) over ...
Scientific Research Publishing18d
Dillard, J., & Brown, J. (2012). Agonistic Pluralism and Imagining CSEAR into the Future. Social and Environmental Accountability Journal, 32, 3-16.
ABSTRACT: Objective: The study explores the transformative consequences of digitalization on accounting and auditing practices, with a particular focus on the context of Bangladesh. This research ...